Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Some skin conditions in pets can signal cancer or may develop into cancer, and monitoring or treating these can help detect or manage the disease.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Cancer drugs often cause temporary hair, skin, nail, and mouth issues.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

Deleting Twist1 in skin cells reduces UVB-induced skin cancer risk.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

A rare adrenal tumor in a 9-year-old girl was successfully treated with surgery.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Bortezomib chemotherapy can cause temporary skin rashes.